These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21403107)

  • 1. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders.
    Finanger Hedderick EL; Simmers JL; Soleimani A; Andres-Mateos E; Marx R; Files DC; King L; Crawford TO; Corse AM; Cohn RD
    Neurology; 2011 Mar; 76(11):960-7. PubMed ID: 21403107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function.
    Zhao J; Yang HT; Wasala L; Zhang K; Yue Y; Duan D; Lai Y
    Mol Med; 2019 Jul; 25(1):31. PubMed ID: 31266455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcolemmal neuronal nitric oxide synthase defect in limb-girdle muscular dystrophy: an adverse modulating factor in the disease course?
    Fanin M; Tasca E; Nascimbeni AC; Angelini C
    J Neuropathol Exp Neurol; 2009 Apr; 68(4):383-90. PubMed ID: 19287313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.
    Lai Y; Thomas GD; Yue Y; Yang HT; Li D; Long C; Judge L; Bostick B; Chamberlain JS; Terjung RL; Duan D
    J Clin Invest; 2009 Mar; 119(3):624-35. PubMed ID: 19229108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcolemma-localized nNOS is required to maintain activity after mild exercise.
    Kobayashi YM; Rader EP; Crawford RW; Iyengar NK; Thedens DR; Faulkner JA; Parikh SV; Weiss RM; Chamberlain JS; Moore SA; Campbell KP
    Nature; 2008 Nov; 456(7221):511-5. PubMed ID: 18953332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcolemmal loss of active nNOS (Nos1) is an oxidative stress-dependent, early event driving disuse atrophy.
    Lechado I Terradas A; Vitadello M; Traini L; Namuduri AV; Gastaldello S; Gorza L
    J Pathol; 2018 Dec; 246(4):433-446. PubMed ID: 30066461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle.
    Balke JE; Zhang L; Percival JM
    Nitric Oxide; 2019 Jan; 82():35-47. PubMed ID: 30503614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.
    Meinen S; Lin S; Rüegg MA; Punga AR
    PLoS One; 2012; 7(8):e44148. PubMed ID: 22952904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin.
    Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC
    J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
    Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.
    Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME
    Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.
    Patel A; Zhao J; Yue Y; Zhang K; Duan D; Lai Y
    Skelet Muscle; 2018 Nov; 8(1):36. PubMed ID: 30466494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
    Chao DS; Silvagno F; Bredt DS
    J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex.
    Grozdanovic Z; Baumgarten HG
    Histol Histopathol; 1999 Jan; 14(1):243-56. PubMed ID: 9987669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4.
    Adams ME; Mueller HA; Froehner SC
    J Cell Biol; 2001 Oct; 155(1):113-22. PubMed ID: 11571312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy.
    Kodippili K; Hakim CH; Yang HT; Pan X; Yang NN; Laughlin MH; Terjung RL; Duan D
    J Physiol; 2018 Nov; 596(21):5199-5216. PubMed ID: 30152022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.
    Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC
    Hum Mol Genet; 2016 Jan; 25(1):158-66. PubMed ID: 26604149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.